Study ID: IXR-201-19-166

Study Title

Multicenter Trial For Patients With Acute Crohn's Disease

Teva Identifier

IXR-201-19-166

ClinicalTrials.gov Identifier

NCT00035503

Study Status

Completed

Trial Condition(s)

Crohn's Disease

Interventions

Drug: etiprednol dicloacetate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
inflammation and infections icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

01/01/2002 - 01/01/2004

Phase

Phase 2

Study Type

Interventional